Implantation of a second glaucoma drainage device

Area of Science:

• Ophthalmology
• Glaucoma Research
• Surgical Interventions

Background:

• Refractory glaucoma presents significant challenges in intraocular pressure (IOP) management.
• Previous glaucoma surgeries may fail, necessitating further interventions.
• Glaucoma drainage devices (GDDs) are used to control IOP in complex cases.

Purpose of the Study:

• To assess the success rate of a second Baerveldt glaucoma implant in controlling IOP.
• To evaluate the reduction in glaucoma medication needs post-implantation.
• To analyze outcomes in patients with refractory glaucoma undergoing a second GDD procedure.

Main Methods:

• Retrospective, noncomparative, interventional study of patients receiving a second GDD.
• Data collected included preoperative and postoperative IOP and number of glaucoma medications (NGM).
• Follow-up extended up to 3 years, with success defined by IOP levels and medication use.

Main Results:

• Mean preoperative IOP of 23.7 mmHg decreased to 14.8 mmHg at 1 year and was maintained below 17 mmHg through 3 years.
• Mean NGM decreased from 3.4 to 2.0 at 1 year, with qualified success rates of 83-88% over 3 years.
• Absolute success for IOP < 21 mmHg was 76% at 1 year; success for IOP < 18 mmHg was 9% at 1 year.

Conclusions:

• A second GDD effectively reduces IOP below 21 mmHg in refractory glaucoma up to 3 years post-implantation.
• Success rates for achieving IOP below 18 mmHg were limited.
• The use of glaucoma medications improved the overall success rate of the second GDD.